- Home
- CADL vs ZYXI Comparison
CADL vs ZYXI Comparison
Compare CADL & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- ZYXI
- Stock Information
- Founded
- CADL 1999
- ZYXI 1996
- Country
- CADL United States
- ZYXI United States
- Employees
- CADL N/A
- ZYXI N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CADL Health Care
- ZYXI Health Care
- Exchange
- CADL Nasdaq
- ZYXI Nasdaq
- Market Cap
- CADL 306.4M
- ZYXI 261.5M
- IPO Year
- CADL 2021
- ZYXI N/A
- Fundamental
- Price
- CADL $11.63
- ZYXI $7.19
- Analyst Decision
- CADL Strong Buy
- ZYXI Strong Buy
- Analyst Count
- CADL 4
- ZYXI 2
- Target Price
- CADL $19.75
- ZYXI $14.00
- AVG Volume (30 Days)
- CADL 1.2M
- ZYXI 66.2K
- Earning Date
- CADL 03-27-2025
- ZYXI 03-07-2025
- Dividend Yield
- CADL N/A
- ZYXI N/A
- EPS Growth
- CADL N/A
- ZYXI N/A
- EPS
- CADL N/A
- ZYXI 0.15
- Revenue
- CADL N/A
- ZYXI $193,665,000.00
- Revenue This Year
- CADL N/A
- ZYXI $10.70
- Revenue Next Year
- CADL N/A
- ZYXI $19.78
- P/E Ratio
- CADL N/A
- ZYXI $48.68
- Revenue Growth
- CADL N/A
- ZYXI 4.21
- 52 Week Low
- CADL $1.34
- ZYXI $7.12
- 52 Week High
- CADL $14.60
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- CADL 72.95
- ZYXI 34.08
- Support Level
- CADL $8.11
- ZYXI $7.27
- Resistance Level
- CADL $13.68
- ZYXI $7.70
- Average True Range (ATR)
- CADL 0.78
- ZYXI 0.28
- MACD
- CADL 0.42
- ZYXI -0.04
- Stochastic Oscillator
- CADL 70.29
- ZYXI 6.93
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.